BRIEF

on Applied DNA Sciences (NASDAQ:APDN )

Applied DNA to Participate in Maxim Healthcare Virtual Summit 2024

Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. Dr. James A. Hayward, the company's president and CEO, will engage in a fireside chat during the summit, which is organized by Maxim Group LLC and runs from October 15th to 17th.

Dr. Hayward's discussion will be conducted by Dr. Jason McCarthy, Maxim's senior managing director and head of Biotechnology Research. The session will be accessible to registered attendees on October 16, 2024, at 12:50 p.m. EDT.

Applied DNA is known for its advancements in DNA and RNA technologies, serving markets in synthetic DNA production, molecular diagnostics, and industrial supply chain security.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Applied DNA Sciences news